0000950170-24-046416.txt : 20240422
0000950170-24-046416.hdr.sgml : 20240422
20240422160512
ACCESSION NUMBER: 0000950170-24-046416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240422
DATE AS OF CHANGE: 20240422
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Corvese Brian
CENTRAL INDEX KEY: 0001393207
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29089
FILM NUMBER: 24861178
MAIL ADDRESS:
STREET 1: C/O ANTIGENICS INC.
STREET 2: 162 FIFTH AVENUE, SUITE 900
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGENUS INC
CENTRAL INDEX KEY: 0001098972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 061562417
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-674-4410
MAIL ADDRESS:
STREET 1: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIGENICS INC /DE/
DATE OF NAME CHANGE: 19991115
4
1
ownership.xml
4
X0508
4
2024-02-05
0001098972
AGENUS INC
AGEN
0001393207
Corvese Brian
C/O AGENUS INC.
3 FORBES ROAD
LEXINGTON
MA
02421
true
false
false
false
false
Stock Option
12.6
2024-02-05
4
A
false
15000
0.00
A
2034-02-05
Common Stock
15000
15000
D
The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 300,000 Stock Options with an exercise price of $0.63.
/s/Christine Klaskin, as Attorney-in-Fact for Brian Corvese
2024-04-22